Skip to main content
Swing Capital

IOL Chemicals & Pharmaceuticals Ltd

NSE: IOLCP BSE: 524164Pharma

IOL Chemicals & Pharmaceuticals Ltd is a leading pharmaceutical (APIs) company and is a significant player in the specialty chemicals space. It serves the domestic and export market.[1]

₹108
52W: ₹67.1 — ₹127
PE 25.4 · Book ₹59.7 · +81% vs book
Market Cap₹3,167 Cr
Stock P/E25.4Price to Earnings
ROCE8.86%Return on Capital
ROE6.13%Return on Equity
Div. Yield0.89%Face Value ₹2

Strengths

  • +Company is almost debt free.
  • +Company has been maintaining a healthy dividend payout of 20.6%
  • +Promoter holding has increased by 4.86% over last quarter.

Weaknesses

  • −The company has delivered a poor sales growth of 1.88% over past five years.
  • −Company has a low return on equity of 8.09% over last 3 years.

Shareholding Pattern

Promoters57.48%
FIIs1.72%
DIIs0.02%
Public40.78%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters48.19%48.19%52.62%▲4.452.62%52.62%52.62%52.62%57.48%▲4.9
FIIs1.39%1.63%▲0.21.49%▼0.11.47%▼0.02.59%▲1.12.25%▼0.32.08%▼0.21.72%▼0.4
DIIs0.09%0.07%▼0.00.08%▲0.00.07%▼0.00.02%▼0.10.05%▲0.00.03%▼0.00.02%▼0.0
Public50.34%50.11%▼0.245.81%▼4.345.84%▲0.044.76%▼1.145.1%▲0.345.26%▲0.240.78%▼4.5

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales545520504502526523528552568580
Expenses481476454452484476465490510523
Operating Profit64445051424763625757
OPM %12%9%10%10%8%9%12%11%10%10%
Net Profit38232830192132343021
EPS ₹1.290.790.961.010.650.71.081.161.020.7

AI Insights

Revenue Trend

TTM revenue at ₹2,227Cr, up 7.1% YoY. OPM at 11%.

Debt Position

Borrowings at ₹159Cr. Debt-to-equity ratio: 0.09x. Healthy balance sheet.

Capex Cycle

CWIP at ₹64Cr (6% of fixed assets). Moderate ongoing capital expenditure.

Institutional Flow

DIIs: 0.02% (-0.23pp change). FIIs: 1.72% (-1.82pp change). Promoters hold 57.48%.

Margin & Efficiency

ROCE declining from 11% (Mar 2014) to 9% (Mar 2025). Working capital days: 58.

Valuation

PE 25.4x with 8.86% ROCE. Price is 81% above book value of ₹59.7. Dividend yield: 0.89%.

Recent Announcements